# Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients

> **NCT05241145** · PHASE1,PHASE2 · COMPLETED · sponsor: **iVeena Delivery Systems, Inc.** · enrollment: 38 (actual)

## Conditions studied

- Keratoconus
- Corneal Ectasia

## Interventions

- **DRUG:** IVMED-80
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05241145
- **Lead sponsor:** iVeena Delivery Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-08
- **Primary completion:** 2020-07-08
- **Final completion:** 2020-07-08
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05241145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05241145, "Safety and Preliminary Efficacy of IVMED-80 Eye Drops in Keratoconus Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05241145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*